메뉴 건너뛰기




Volumn 65, Issue 3, 2015, Pages 281-294

Device-detected atrial fibrillation: What to do with asymptomatic patients?

Author keywords

atrial tachyarrhythmias; cardiac implantable electronic devices; cerebral embolism; defibrillator; implantable cardiac monitor; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; THROMBIN INHIBITOR; WARFARIN;

EID: 84921347198     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.045     Document Type: Review
Times cited : (48)

References (77)
  • 1
    • 84893651437 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2014 update: A report from the American Heart Association
    • for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • A.S. Go, D. Mozaffarian, V.L. Roger for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
    • (2014) Circulation , vol.129 , pp. e28-e292
    • Go, A.S.1    Mozaffarian, D.2    Roger, V.L.3
  • 2
    • 84899623290 scopus 로고    scopus 로고
    • The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms
    • J. Andrade, P. Khairy, and D. Dobrev The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms Circ Res 114 2014 1453 1468
    • (2014) Circ Res , vol.114 , pp. 1453-1468
    • Andrade, J.1    Khairy, P.2    Dobrev, D.3
  • 3
    • 84921398526 scopus 로고    scopus 로고
    • National Stroke Association Available at:. Accessed November 7, 2014
    • National Stroke Association. NSAFactSheet-Afib-2013. 2013. Available at: http://www.stroke.org/sites/default/files/resources/NSA-FactSheet-Afib-2014.pdf. Accessed November 7, 2014.
    • (2013) NSAFactSheet-Afib-2013
  • 4
    • 84884904417 scopus 로고    scopus 로고
    • Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. Adult population
    • S. Colilla, A. Crow, and W. Petkun Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. Adult population Am J Cardiol 112 2013 1142 1147
    • (2013) Am J Cardiol , vol.112 , pp. 1142-1147
    • Colilla, S.1    Crow, A.2    Petkun, W.3
  • 5
    • 84890100326 scopus 로고    scopus 로고
    • Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
    • B.P. Krijthe, A. Kunst, and E.J. Benjamin Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur Heart J 34 2013 2746 2751
    • (2013) Eur Heart J , vol.34 , pp. 2746-2751
    • Krijthe, B.P.1    Kunst, A.2    Benjamin, E.J.3
  • 6
    • 84896723562 scopus 로고    scopus 로고
    • Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study
    • S.S. Chugh, R. Havmoeller, and K. Narayanan Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation 129 2014 837 847
    • (2014) Circulation , vol.129 , pp. 837-847
    • Chugh, S.S.1    Havmoeller, R.2    Narayanan, K.3
  • 7
    • 84897831871 scopus 로고    scopus 로고
    • Role of the autonomic nervous system in modulating cardiac arrhythmias
    • M.J. Shen, and D.P. Zipes Role of the autonomic nervous system in modulating cardiac arrhythmias Circ Res 114 2014 1004 1021
    • (2014) Circ Res , vol.114 , pp. 1004-1021
    • Shen, M.J.1    Zipes, D.P.2
  • 8
    • 84902108870 scopus 로고    scopus 로고
    • Atrial remodeling and atrial fibrillation: Recent advances and translational perspectives
    • S. Nattel, and M. Harada Atrial remodeling and atrial fibrillation: recent advances and translational perspectives J Am Coll Cardiol 63 2014 2335 2345
    • (2014) J Am Coll Cardiol , vol.63 , pp. 2335-2345
    • Nattel, S.1    Harada, M.2
  • 9
    • 0029099346 scopus 로고
    • Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
    • M.C. Wijffels, C.J. Kirchhof, and R. Dorland Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
    • (1995) Circulation , vol.92 , pp. 1954-1968
    • Wijffels, M.C.1    Kirchhof, C.J.2    Dorland, R.3
  • 10
    • 44049107793 scopus 로고    scopus 로고
    • Atrial fibrillation begets atrial fibrillation in the pulmonary veins: On the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans
    • T. Rostock, D. Steven, and B. Lutomsky Atrial fibrillation begets atrial fibrillation in the pulmonary veins: on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans J Am Coll Cardiol 51 2008 2153 2160
    • (2008) J Am Coll Cardiol , vol.51 , pp. 2153-2160
    • Rostock, T.1    Steven, D.2    Lutomsky, B.3
  • 11
    • 84921407908 scopus 로고    scopus 로고
    • TeamAFib Boehringer Ingelheim Pharmaceuticals Inc. Available at:. Accessed November 7, 2014
    • TeamAFib. What is Atrial Fibrillation? Boehringer Ingelheim Pharmaceuticals Inc. 2013. Available at: https://www.teamafib.com/about-afib/what-is-afib/. Accessed November 7, 2014.
    • (2013) What is Atrial Fibrillation?
  • 12
    • 0030953564 scopus 로고    scopus 로고
    • Stroke recurrence: Predictors, severity, and prognosis. the Copenhagen Stroke Study
    • H.S. Jorgensen, H. Nakayama, and J. Reith Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study Neurology 48 1997 891 895
    • (1997) Neurology , vol.48 , pp. 891-895
    • Jorgensen, H.S.1    Nakayama, H.2    Reith, J.3
  • 13
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. the Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators N Engl J Med 323 1990 1505 1511
    • (1990) N Engl J Med , vol.323 , pp. 1505-1511
  • 14
    • 0028845685 scopus 로고
    • Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators
    • M.D. Ezekowitz, K.E. James, and S.M. Nazarian Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Circulation 92 1995 2178 2182
    • (1995) Circulation , vol.92 , pp. 2178-2182
    • Ezekowitz, M.D.1    James, K.E.2    Nazarian, S.M.3
  • 15
    • 0025814587 scopus 로고
    • Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
    • S.J. Connolly, A. Laupacis, and M. Gent Canadian Atrial Fibrillation Anticoagulation (CAFA) Study J Am Coll Cardiol 18 1991 349 355
    • (1991) J Am Coll Cardiol , vol.18 , pp. 349-355
    • Connolly, S.J.1    Laupacis, A.2    Gent, M.3
  • 16
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • A.S. Go, E.M. Hylek, and Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
    • (2003) JAMA , vol.290 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3
  • 17
    • 84907011613 scopus 로고    scopus 로고
    • Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation
    • C.A. Salazar, D. del Aguila, and E.G. Cordova Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation Cochrane Database Syst Rev 3 2014 Cd009893
    • (2014) Cochrane Database Syst Rev , vol.3 , pp. Cd009893
    • Salazar, C.A.1    Del Aguila, D.2    Cordova, E.G.3
  • 18
    • 84903485570 scopus 로고    scopus 로고
    • Cryptogenic stroke and underlying atrial fibrillation
    • for the CRYSTAL AF Investigators
    • T. Sanna, H.C. Diener, R.S. Passman for the CRYSTAL AF Investigators Cryptogenic stroke and underlying atrial fibrillation N Engl J Med 370 2014 2478 2486
    • (2014) N Engl J Med , vol.370 , pp. 2478-2486
    • Sanna, T.1    Diener, H.C.2    Passman, R.S.3
  • 19
    • 84903446651 scopus 로고    scopus 로고
    • Atrial fibrillation in patients with cryptogenic stroke
    • for the EMBRACE Investigators and Coordinators
    • D.J. Gladstone, M. Spring, P. Dorian for the EMBRACE Investigators and Coordinators Atrial fibrillation in patients with cryptogenic stroke N Engl J Med 370 2014 2467 2477
    • (2014) N Engl J Med , vol.370 , pp. 2467-2477
    • Gladstone, D.J.1    Spring, M.2    Dorian, P.3
  • 20
    • 84872678590 scopus 로고    scopus 로고
    • Pacemaker-detected atrial fibrillation in patients with pacemakers: Prevalence, predictors, and current use of oral anticoagulation
    • J.S. Healey, J.L. Martin, and A. Duncan Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation Can J Cardiol 29 2013 224 228
    • (2013) Can J Cardiol , vol.29 , pp. 224-228
    • Healey, J.S.1    Martin, J.L.2    Duncan, A.3
  • 21
    • 58149204184 scopus 로고    scopus 로고
    • Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
    • T. Watson, E. Shantsila, and G.Y. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
    • (2009) Lancet , vol.373 , pp. 155-166
    • Watson, T.1    Shantsila, E.2    Lip, G.Y.3
  • 22
    • 81355142736 scopus 로고    scopus 로고
    • Atrial fibrillation pathophysiology: Implications for management
    • Y.K. Iwasaki, K. Nishida, and T. Kato Atrial fibrillation pathophysiology: implications for management Circulation 124 2011 2264 2274
    • (2011) Circulation , vol.124 , pp. 2264-2274
    • Iwasaki, Y.K.1    Nishida, K.2    Kato, T.3
  • 23
    • 0032945720 scopus 로고    scopus 로고
    • Aortic plaque in atrial fibrillation: Prevalence, predictors, and thromboembolic implications
    • J.L. Blackshear, L.A. Pearce, and R.G. Hart Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications Stroke 30 1999 834 840
    • (1999) Stroke , vol.30 , pp. 834-840
    • Blackshear, J.L.1    Pearce, L.A.2    Hart, R.G.3
  • 24
    • 0032723885 scopus 로고    scopus 로고
    • Left atrial appendage: Structure, function, and role in thromboembolism
    • N.M. Al-Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 554
    • (1999) Heart , vol.82 , pp. 547-554
    • Al-Saady, N.M.1    Obel, O.A.2    Camm, A.J.3
  • 25
    • 0037161359 scopus 로고    scopus 로고
    • Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience
    • H. Sievert, M.D. Lesh, and T. Trepels Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience Circulation 105 2002 1887 1889
    • (2002) Circulation , vol.105 , pp. 1887-1889
    • Sievert, H.1    Lesh, M.D.2    Trepels, T.3
  • 26
    • 68349151861 scopus 로고    scopus 로고
    • Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial
    • D.R. Holmes, V.Y. Reddy, and Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
    • (2009) Lancet , vol.374 , pp. 534-542
    • Holmes, D.R.1    Reddy, V.Y.2    Turi, Z.G.3
  • 27
    • 84874001138 scopus 로고    scopus 로고
    • Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial
    • for the PROTECT AF Investigators
    • V.Y. Reddy, S.K. Doshi, H. Sievert for the PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial Circulation 127 2013 720 729
    • (2013) Circulation , vol.127 , pp. 720-729
    • Reddy, V.Y.1    Doshi, S.K.2    Sievert, H.3
  • 28
    • 84903828960 scopus 로고    scopus 로고
    • Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial
    • D.R. Holmes Jr., S. Kar, and M.J. Price Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial J Am Coll Cardiol 64 2014 1 12
    • (2014) J Am Coll Cardiol , vol.64 , pp. 1-12
    • Holmes, Jr.D.R.1    Kar, S.2    Price, M.J.3
  • 29
    • 84912058235 scopus 로고    scopus 로고
    • Food and Drug Administration. Available at:. Accessed November 27, 2014
    • FDA Executive Summary. Boston Scientific Watchman Left Atrial Appendage Closure Therapy. Food and Drug Administration. Available at: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/circulatorysystemdevicespanel/ucm419373.pdf. Accessed November 27, 2014.
    • FDA Executive Summary. Boston Scientific Watchman Left Atrial Appendage Closure Therapy
  • 30
    • 84864758434 scopus 로고    scopus 로고
    • Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study
    • L. Di Biase, P. Santangeli, and M. Anselmino Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study J Am Coll Cardiol 60 2012 531 538
    • (2012) J Am Coll Cardiol , vol.60 , pp. 531-538
    • Di Biase, L.1    Santangeli, P.2    Anselmino, M.3
  • 31
    • 84891675972 scopus 로고    scopus 로고
    • Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation
    • M. Anselmino, M. Scaglione, and L. Di Biase Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation Heart Rhythm 11 2014 2 7
    • (2014) Heart Rhythm , vol.11 , pp. 2-7
    • Anselmino, M.1    Scaglione, M.2    Di Biase, L.3
  • 32
    • 0037382858 scopus 로고    scopus 로고
    • Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
    • for the MOST Investigators
    • T.V. Glotzer, A.S. Hellkamp, J. Zimmerman for the MOST Investigators Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) Circulation 107 2003 1614 1619
    • (2003) Circulation , vol.107 , pp. 1614-1619
    • Glotzer, T.V.1    Hellkamp, A.S.2    Zimmerman, J.3
  • 33
    • 70449520921 scopus 로고    scopus 로고
    • The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study
    • T.V. Glotzer, E.G. Daoud, and D.G. Wyse The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
    • (2009) Circ Arrhythm Electrophysiol , vol.2 , pp. 474-480
    • Glotzer, T.V.1    Daoud, E.G.2    Wyse, D.G.3
  • 34
    • 84855483311 scopus 로고    scopus 로고
    • Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS
    • for the TRENDS Investigators
    • E.G. Daoud, T.V. Glotzer, D.G. Wyse for the TRENDS Investigators Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS Heart Rhythm 8 2011 1416 1423
    • (2011) Heart Rhythm , vol.8 , pp. 1416-1423
    • Daoud, E.G.1    Glotzer, T.V.2    Wyse, D.G.3
  • 35
    • 0034940478 scopus 로고    scopus 로고
    • The use of permanent pacemakers in the detection of cardiac arrhythmias
    • C.J. Plummer, S. Henderson, and L. Gardener The use of permanent pacemakers in the detection of cardiac arrhythmias Europace 3 2001 229 232
    • (2001) Europace , vol.3 , pp. 229-232
    • Plummer, C.J.1    Henderson, S.2    Gardener, L.3
  • 36
    • 3242769132 scopus 로고    scopus 로고
    • Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies
    • H. Purerfellner, A.M. Gillis, and R. Holbrook Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies Pacing Clin Electrophysiol 27 2004 983 992
    • (2004) Pacing Clin Electrophysiol , vol.27 , pp. 983-992
    • Purerfellner, H.1    Gillis, A.M.2    Holbrook, R.3
  • 37
    • 4143107795 scopus 로고    scopus 로고
    • Detection of atrial fibrillation by permanent pacemakers: Observations from the STOP AF trial
    • STOP AF Trial
    • C.J. Plummer, J.M. McComb STOP AF Trial Detection of atrial fibrillation by permanent pacemakers: observations from the STOP AF trial Cardiac Electrophysiol Rev 7 2003 333 340
    • (2003) Cardiac Electrophysiol Rev , vol.7 , pp. 333-340
    • Plummer, C.J.1    McComb, J.M.2
  • 38
    • 33750377141 scopus 로고    scopus 로고
    • Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording
    • W.G. de Voogt, N.M. van Hemel, and A.A. van de Bos Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording Europace 8 2006 950 961
    • (2006) Europace , vol.8 , pp. 950-961
    • De Voogt, W.G.1    Van Hemel, N.M.2    Van De Bos, A.A.3
  • 39
    • 77951896083 scopus 로고    scopus 로고
    • Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial
    • for the XPECT Trial Investigators
    • G. Hindricks, E. Pokushalov, L. Urban for the XPECT Trial Investigators Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial Circ Arrhythm Electrophysiol 3 2010 141 147
    • (2010) Circ Arrhythm Electrophysiol , vol.3 , pp. 141-147
    • Hindricks, G.1    Pokushalov, E.2    Urban, L.3
  • 40
    • 84864426256 scopus 로고    scopus 로고
    • Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT
    • for the ASSERT Steering Committee and Investigators
    • E.S. Kaufman, C.W. Israel, G.M. Nair for the ASSERT Steering Committee and Investigators Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT Heart Rhythm 9 2012 1241 1246
    • (2012) Heart Rhythm , vol.9 , pp. 1241-1246
    • Kaufman, E.S.1    Israel, C.W.2    Nair, G.M.3
  • 41
    • 0035029328 scopus 로고    scopus 로고
    • Pacemaker repetitive nonreentrant ventriculoatrial synchronous rhythm. A review
    • S.S. Barold, and P.A. Levine Pacemaker repetitive nonreentrant ventriculoatrial synchronous rhythm. A review J Interv Card Electrophysiol 5 2001 45 58
    • (2001) J Interv Card Electrophysiol , vol.5 , pp. 45-58
    • Barold, S.S.1    Levine, P.A.2
  • 42
    • 77957569137 scopus 로고    scopus 로고
    • Repetitive Nonreentrant Ventriculoatrial Synchrony (RNRVAS)
    • J. Francis Repetitive Nonreentrant Ventriculoatrial Synchrony (RNRVAS) Indian Pacing Electrophysiol J 10 2010 203 204
    • (2010) Indian Pacing Electrophysiol J , vol.10 , pp. 203-204
    • Francis, J.1
  • 43
    • 0025943182 scopus 로고
    • Repetitive reentrant and non-reentrant ventriculoatrial synchrony in dual chamber pacing
    • S.S. Barold Repetitive reentrant and non-reentrant ventriculoatrial synchrony in dual chamber pacing Clinical Cardiol 14 1991 754 763
    • (1991) Clinical Cardiol , vol.14 , pp. 754-763
    • Barold, S.S.1
  • 44
    • 77957561225 scopus 로고    scopus 로고
    • Multiple episodes of presyncope in a pacemaker dependent patient: What is the diagnosis?
    • S.K. Mulpuru, and C. Saponieri Multiple episodes of presyncope in a pacemaker dependent patient: what is the diagnosis? Indian Pacing Electrophysiol J 10 2010 233 235
    • (2010) Indian Pacing Electrophysiol J , vol.10 , pp. 233-235
    • Mulpuru, S.K.1    Saponieri, C.2
  • 45
    • 84862862583 scopus 로고    scopus 로고
    • Pacemaker repetitive nonreentrant ventriculoatrial synchrony. Why did automatic mode switching occur?
    • S.S. Barold, R.X. Stroobandt, and F. Van Heuverswyn Pacemaker repetitive nonreentrant ventriculoatrial synchrony. Why did automatic mode switching occur? J Electrocardiol 45 2012 420 425
    • (2012) J Electrocardiol , vol.45 , pp. 420-425
    • Barold, S.S.1    Stroobandt, R.X.2    Van Heuverswyn, F.3
  • 46
    • 0031839307 scopus 로고    scopus 로고
    • Atrial fibrillation and anticoagulation in patients with permanent pacemakers: Implications for stroke prevention
    • P.B. Sparks, H.G. Mond, and J.M. Kalman Atrial fibrillation and anticoagulation in patients with permanent pacemakers: implications for stroke prevention Pacing Clin Electrophysiol 21 1998 1258 1267
    • (1998) Pacing Clin Electrophysiol , vol.21 , pp. 1258-1267
    • Sparks, P.B.1    Mond, H.G.2    Kalman, J.M.3
  • 47
    • 0037071799 scopus 로고    scopus 로고
    • Ventricular pacing or dual-chamber pacing for sinus-node dysfunction
    • for the Mode Selection Trial in Sinus-Node Dysfunction
    • G.A. Lamas, K.L. Lee, M.O. Sweeney for the Mode Selection Trial in Sinus-Node Dysfunction Ventricular pacing or dual-chamber pacing for sinus-node dysfunction N Engl J Med 346 2002 1854 1862
    • (2002) N Engl J Med , vol.346 , pp. 1854-1862
    • Lamas, G.A.1    Lee, K.L.2    Sweeney, M.O.3
  • 48
    • 84856263164 scopus 로고    scopus 로고
    • Device-detected atrial tachyarrhythmias: What do we know?
    • J.S. Healey Device-detected atrial tachyarrhythmias: what do we know? Europace 14 2012 157 158
    • (2012) Europace , vol.14 , pp. 157-158
    • Healey, J.S.1
  • 49
    • 34548414621 scopus 로고    scopus 로고
    • Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease
    • for the Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial
    • M.O. Sweeney, A.J. Bank, E. Nsah for the Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease N Engl J Med 357 2007 1000 1008
    • (2007) N Engl J Med , vol.357 , pp. 1000-1008
    • Sweeney, M.O.1    Bank, A.J.2    Nsah, E.3
  • 50
    • 33745642933 scopus 로고    scopus 로고
    • Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: The TRENDS study
    • T.V. Glotzer, E.G. Daoud, and D.G. Wyse Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study J Interv Card Electrophysiol 15 2006 9 14
    • (2006) J Interv Card Electrophysiol , vol.15 , pp. 9-14
    • Glotzer, T.V.1    Daoud, E.G.2    Wyse, D.G.3
  • 51
    • 74549186552 scopus 로고    scopus 로고
    • Everything counts in large amounts: Device-detected atrial high-rate arrhythmias
    • J.F. Viles-Gonzalez, and J.L. Halperin Everything counts in large amounts: device-detected atrial high-rate arrhythmias Circ Arrhythm Electrophysiol 2 2009 471 473
    • (2009) Circ Arrhythm Electrophysiol , vol.2 , pp. 471-473
    • Viles-Gonzalez, J.F.1    Halperin, J.L.2
  • 52
    • 84862909359 scopus 로고    scopus 로고
    • Subclinical atrial fibrillation and the risk of stroke
    • for the ASSERT Investigators
    • J.S. Healey, S.J. Connolly, M.R. Gold for the ASSERT Investigators Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
    • (2012) N Engl J Med , vol.366 , pp. 120-129
    • Healey, J.S.1    Connolly, S.J.2    Gold, M.R.3
  • 53
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 54
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • G.Y. Lip, R. Nieuwlaat, and R. Pisters Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3
  • 55
    • 84856004708 scopus 로고    scopus 로고
    • How much atrial fibrillation is too much atrial fibrillation?
    • G. Lamas How much atrial fibrillation is too much atrial fibrillation? N Engl J Med 366 2012 178 180
    • (2012) N Engl J Med , vol.366 , pp. 178-180
    • Lamas, G.1
  • 57
    • 84901603173 scopus 로고    scopus 로고
    • Temporal relationship between subclinical atrial fibrillation and embolic events
    • for the ASSERT Investigators
    • M. Brambatti, S.J. Connolly, M.R. Gold for the ASSERT Investigators Temporal relationship between subclinical atrial fibrillation and embolic events Circulation 129 2014 2094 2099
    • (2014) Circulation , vol.129 , pp. 2094-2099
    • Brambatti, M.1    Connolly, S.J.2    Gold, M.R.3
  • 58
    • 84856293368 scopus 로고    scopus 로고
    • Detection of atrial high-rate events by continuous home monitoring: Clinical significance in the heart failure-cardiac resynchronization therapy population
    • N. Shanmugam, A. Boerdlein, and J. Proff Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population Europace 14 2012 230 237
    • (2012) Europace , vol.14 , pp. 230-237
    • Shanmugam, N.1    Boerdlein, A.2    Proff, J.3
  • 60
    • 19444384304 scopus 로고    scopus 로고
    • Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
    • D.G. Sherman, S.G. Kim, and B.S. Boop Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191
    • (2005) Arch Intern Med , vol.165 , pp. 1185-1191
    • Sherman, D.G.1    Kim, S.G.2    Boop, B.S.3
  • 61
    • 0042387879 scopus 로고    scopus 로고
    • Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
    • E.M. Hylek, A.S. Go, and Y. Chang Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019 1026
    • (2003) N Engl J Med , vol.349 , pp. 1019-1026
    • Hylek, E.M.1    Go, A.S.2    Chang, Y.3
  • 62
    • 74349084072 scopus 로고    scopus 로고
    • Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS])
    • Y. Schwammenthal, N. Bornstein, and E. Schwammenthal Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]) Am J Cardiol 105 2010 411 416
    • (2010) Am J Cardiol , vol.105 , pp. 411-416
    • Schwammenthal, Y.1    Bornstein, N.2    Schwammenthal, E.3
  • 63
    • 33746954539 scopus 로고    scopus 로고
    • Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: An observational study
    • for the Investigators of the Registry of the Canadian Stroke Network
    • M. O'Donnell, W. Oczkowski, J. Fang for the Investigators of the Registry of the Canadian Stroke Network Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study Lancet Neurol 5 2006 749 754
    • (2006) Lancet Neurol , vol.5 , pp. 749-754
    • O'Donnell, M.1    Oczkowski, W.2    Fang, J.3
  • 64
    • 60549096887 scopus 로고    scopus 로고
    • Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated
    • D.J. Gladstone, E. Bui, and J. Fang Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated Stroke 40 2009 235 240
    • (2009) Stroke , vol.40 , pp. 235-240
    • Gladstone, D.J.1    Bui, E.2    Fang, J.3
  • 65
    • 6444240752 scopus 로고    scopus 로고
    • Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin
    • B.F. Gage, C. van Walraven, and L. Pearce Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 2004 2287 2292
    • (2004) Circulation , vol.110 , pp. 2287-2292
    • Gage, B.F.1    Van Walraven, C.2    Pearce, L.3
  • 66
    • 79551645746 scopus 로고    scopus 로고
    • Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study
    • J.B. Olesen, G.Y. Lip, and M.L. Hansen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
    • (2011) BMJ , vol.342 , pp. d124
    • Olesen, J.B.1    Lip, G.Y.2    Hansen, M.L.3
  • 67
    • 78650414688 scopus 로고    scopus 로고
    • Identifying patients at high risk for stroke despite anticoagulation: A comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort
    • G.Y. Lip, L. Frison, and J.L. Halperin Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort Stroke 41 2010 2731 2738
    • (2010) Stroke , vol.41 , pp. 2731-2738
    • Lip, G.Y.1    Frison, L.2    Halperin, J.L.3
  • 68
    • 84868523625 scopus 로고    scopus 로고
    • ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • A.J. Camm, G.Y. Lip, and R. De Caterina ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
    • (2012) Eur Heart J , vol.33 , pp. 2719-2747
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3
  • 69
    • 84908220640 scopus 로고    scopus 로고
    • 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
    • C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
    • (2014) J Am Coll Cardiol , vol.64 , pp. e1-e76
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3
  • 70
    • 84856745317 scopus 로고    scopus 로고
    • Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • for the American College of Chest Physicians
    • J.J. You, D.E. Singer, P.A. Howard for the American College of Chest Physicians Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 Suppl 2 2012 e531S e575S
    • (2012) Chest , vol.1412 , pp. e531S-e575S
    • You, J.J.1    Singer, D.E.2    Howard, P.A.3
  • 71
    • 84907965406 scopus 로고    scopus 로고
    • 2014 focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation
    • for the CCS Atrial Fibrillation Guidelines Committee
    • A. Verma, J.A. Cairns, L.B. Mitchell for the CCS Atrial Fibrillation Guidelines Committee 2014 focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation Can J Cardiol 30 2014 1114 1130
    • (2014) Can J Cardiol , vol.30 , pp. 1114-1130
    • Verma, A.1    Cairns, J.A.2    Mitchell, L.B.3
  • 72
    • 84055184415 scopus 로고    scopus 로고
    • Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
    • P. Kirchhof, G.Y. Lip, and I.C. Van Gelder Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference Europace 14 2012 8 27
    • (2012) Europace , vol.14 , pp. 8-27
    • Kirchhof, P.1    Lip, G.Y.2    Van Gelder, I.C.3
  • 73
    • 80054914090 scopus 로고    scopus 로고
    • Pacemaker clinic: An opportunity to detect silent atrial fibrillation and improve antithrombotic treatment
    • S. Cabrera, J. Mercé, and R. de Castro Pacemaker clinic: an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment Europace 13 2011 1574 1579
    • (2011) Europace , vol.13 , pp. 1574-1579
    • Cabrera, S.1    Mercé, J.2    De Castro, R.3
  • 74
    • 24944491712 scopus 로고    scopus 로고
    • Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database)
    • for the AFFIRM Investigators
    • G.E. O'Hara, L. Charbonneau, M. Chandler for the AFFIRM Investigators Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database) Am J Cardiol 96 2005 815 821
    • (2005) Am J Cardiol , vol.96 , pp. 815-821
    • O'Hara, G.E.1    Charbonneau, L.2    Chandler, M.3
  • 75
    • 84880931208 scopus 로고    scopus 로고
    • Current practice for diagnosis and management of silent atrial fibrillation: Results of the European Heart Rhythm Association survey
    • for the Scientific Initiatives Committee, European Heart Rhythm Association
    • D. Dobreanu, J.H. Svendsen, T. Lewalter for the Scientific Initiatives Committee, European Heart Rhythm Association Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey Europace 15 2013 1223 1225
    • (2013) Europace , vol.15 , pp. 1223-1225
    • Dobreanu, D.1    Svendsen, J.H.2    Lewalter, T.3
  • 76
    • 84862519332 scopus 로고    scopus 로고
    • Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study
    • M. Landolina, G.B. Perego, and M. Lunati Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study Circulation 125 2012 2985 2992
    • (2012) Circulation , vol.125 , pp. 2985-2992
    • Landolina, M.1    Perego, G.B.2    Lunati, M.3
  • 77
    • 84878955082 scopus 로고    scopus 로고
    • The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: A commercial insurer perspective
    • J.P. Casciano, Z.J. Dotiwala, and B.C. Martin The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective J Manag Care Pharm 19 2013 302 316
    • (2013) J Manag Care Pharm , vol.19 , pp. 302-316
    • Casciano, J.P.1    Dotiwala, Z.J.2    Martin, B.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.